Comirnaty for 5 to 11 years old (bivalent, Original/Omicron BA.4-5)

(Note 2)Partial Change Approval

Coronavirus Modified Uridine RNA Vaccine (SARS-CoV-2) (active ingredients: tozinameran and famtozinameran)

Approval Information

Brand NameComirnaty for 5 to 11 years old (bivalent, Original/Omicron BA.4-5)

Generic NameCoronavirus Modified Uridine RNA Vaccine (SARS-CoV-2) (active ingredients: tozinameran and famtozinameran)

ApprovedFebruary 2023

Type(Note 2)Partial Change Approval

Review Reports

English Review Report

PDF · 502.20 KB

Japanese Review Report

PDF · 646.51 KB

Want structured data, translation summaries & alerts?

PharmaLens is building the most comprehensive English-language PMDA intelligence platform. Join the waitlist for early access.

Join the Waitlist

Source: PMDA Website. Review reports are provided under Japan's Public Data License v1.0. Translations and structured data by PharmaLens are unofficial and for reference only.

← Back to Drug Database